Generex Biotechnology Partner Olaregen Therapeutix Inc. Signs Manufacturing Agreements for Excellagen® Wound Healing Collagen Matrix Collagen Solutions & Berkshire Sterile Manufacturing to Supply ...

WORCESTER, Mass., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced ...

Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products ...

Ii-Key-SARS-CoV-2 vaccine generates vaccine-specific antibodies and T cell responses in a transgenic mouse model The Ii-Key vaccine elicits both CD4+ T Helper cell (Th1) and CD8+ responses that are ...

WORCESTER, Mass., Aug. 27, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com ), the leader in drug delivery for metabolic diseases through the inner lining of ...

Generex Biotechnology Corporation, a company engaged in the research, development, and commercialization of drug delivery systems and technologies, has entered into a non-binding Letter of Intent (LoI ...

MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that the company has relaunched its corporate website to provide details on a revamped ...

SIA "Generex Biotechnology BALTIC" to Focus On Registration Efforts in the Baltic Region and Europe for All Company Developments and Products WORCESTER, Mass., Sep 2 ...

Generex’s Ii-Key peptide vaccines for infectious disease and cancer have been studied in human clinical trials involving over 300 subjects in Phase I and Phase II ...

Filing of up-list application to Nasdaq Details on 1:1 Shareholder stock dividend Recording and transcript of shareholders conference call available at www.generex.com “Lastly, it is important to note ...

Generex to receive $10M in common stock, a warrant, & $1M in R&D funding WORCESTER, Mass. and TORONTO, April 23, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) ...

MIRAMAR, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company ...